TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
TCL Archive Special Report on Cancer Centers: Three cancer centers win $9 million core grants, 11 of 13 competitors cut due to NCI budget shortfall. January 16, 2004
